É. Hachulla

Research interests

Publications

• Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

  Annals of the Rheumatic Diseases · 2021 · https://doi.org/10.1136/annrheumdis-2020-219498

• COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

  The Lancet Rheumatology · 2021 · https://doi.org/10.1016/s2665-9913(21)00059-x

• Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

  Autoimmunity Reviews · 2020 · 10.1016/j.autrev.2020.102458

• Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

  Annals of the Rheumatic Diseases · 2020 · 10.1136/annrheumdis-2020-217455

• Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

  JAMA Neurology · 2018 · 10.1001/jamaneurol.2018.2598

• Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

  Journal of Allergy and Clinical Immunology · 2017 · https://doi.org/10.1016/j.jaci.2016.12.978

• Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

  European Heart Journal · 2017 · https://doi.org/10.1093/eurheartj/ehx321

• Mapping and predicting mortality from systemic sclerosis

  Annals of the Rheumatic Diseases · 2017 · https://doi.org/10.1136/annrheumdis-2017-211448

• Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

  Journal of Medical Genetics · 2016 · https://doi.org/10.1136/jmedgenet-2016-104178

• Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

  Annals of the Rheumatic Diseases · 2014 · 10.1136/annrheumdis-2013-204838

• Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2014-206008

• Treatment of Primary Sjögren Syndrome With Rituximab

  Annals of Internal Medicine · 2014 · https://doi.org/10.7326/m13-1085

• Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

  Annals of the Rheumatic Diseases · 2014 · https://doi.org/10.1136/annrheumdis-2013-204615

• Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation

  Blood · 2014 · https://doi.org/10.1182/blood-2013-12-543793

• Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity

  Autoimmunity Reviews · 2012 · https://doi.org/10.1016/j.autrev.2012.06.006

• Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survival

  Arthritis & Rheumatism · 2011 · https://doi.org/10.1002/art.30541

• EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome

  Annals of the Rheumatic Diseases · 2011 · https://doi.org/10.1136/ard.2010.143743

• Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

  Circulation · 2010 · 10.1161/circulationaha.109.911818

• Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

  Arthritis & Rheumatism · 2010 · https://doi.org/10.1002/art.27541

• Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

  Arthritis & Rheumatism · 2010 · https://doi.org/10.1002/art.27555

• Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

  Annals of the Rheumatic Diseases · 2010 · 10.1136/ard.2009.114264

• Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

  New England Journal of Medicine · 2009 · 10.1056/nejmoa0810787

• Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

  Annals of the Rheumatic Diseases · 2008 · https://doi.org/10.1136/ard.2008.093179

• Infections in 252 Patients with Common Variable Immunodeficiency

  Clinical Infectious Diseases · 2008 · 10.1086/587669

• High N‐terminal pro–brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis

  Arthritis & Rheumatism · 2007 · https://doi.org/10.1002/art.23187

• Pulmonary Arterial Hypertension in France

  American Journal of Respiratory and Critical Care Medicine · 2006 · 10.1164/rccm.200510-1668oc

• Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

  Arthritis & Rheumatism · 2005 · https://doi.org/10.1002/art.21433

• Neurologic Manifestations in Primary Sjögren Syndrome

  Medicine · 2004 · https://doi.org/10.1097/01.md.0000141099.53742.16

• Inefficacy of infliximab in primary Sjögren's syndrome: Results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSS)

  Arthritis & Rheumatism · 2004 · https://doi.org/10.1002/art.20146

• Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

  Arthritis & Rheumatism · 2004 · https://doi.org/10.1002/art.20676

• Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

  Arthritis & Rheumatism · 2002 · https://doi.org/10.1002/art.10187

• Interstitial lung disease in polymyositis and dermatomyositis

  Arthritis Care & Research · 2002 · 10.1002/art.10794

• A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis

  Arthritis & Rheumatism · 1997 · https://doi.org/10.1002/art.1780401213

Current projects

No projects listed.